Moreover, the activated DCs engulf cancer-specific antigens released from the ruptured tumor cells thereby converting into mature DCs, which can prime and educate naive T cells to become cancer-specific CD8+ T effector cells [24], [31]. The gene discussed is CD8A; the disease is cancer.